Sevamontree Chadapa, Jintajirapan Supreeya, Phakdeekitcharoen Pran, Phakdeekitcharoen Bunyong
Division of Nephrology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Outpatient Intervention and Urgency Care, Department of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Int J Nephrol. 2024 Jan 22;2024:5694131. doi: 10.1155/2024/5694131. eCollection 2024.
Hyperkalemia is a life-threatening condition in outpatient and emergency departments. Hyperkalemia is associated with more events of major adverse cardiovascular diseases, hospitalization, and death. The aim of this study is to study and assess the prevalence and risk factors for developing hyperkalemia within the Thai population.
A cross-sectional observational study of 3,299 unique adult patients (≥18 years) in one calendar year (2021) with at least 1 valid serum potassium (SK) test was conducted in the outpatient department of medicine. Hyperkalemia was determined as SK ≥5.8 mmol/L without hemolysis or technical error. Clinical data and laboratory tests were collected for analysis of risk factors.
2,971 patients (131 hyperkalemia and 2,840 control) were eligible. The annual prevalence of hyperkalemia was 4.41%. The mean ages of patients were 66.5 years in the hyperkalemia group and 55.9 years in the control group. Increasing age had a positive association ( = 0.220, < 0.001) to risk of hyperkalemia, whereas the estimated glomerular filtration rate (eGFR) had an inverse association with SK level ( = -0.398, < 0.001). The risk factors for hyperkalemia were patients with age ≥65 years (odds ratio, 2.106; 95% CI, 1.399, 3.171; < 0.001), presence of diabetes mellitus (DM, odds ratio, 1.541; 95% CI, 1.030, 2.306; = 0.036), chronic kidney disease (CKD) stage ≥3 (odds ratio, 14.885; 95% CI, 8.112, 27.313; < 0.001), hemodialysis treatment (odds ratio, 10.170; 95% CI, 5.858, 17.657; < 0.001), and usage of renin-angiotensin-aldosterone system inhibitors (RAASi, odds ratio, 2.256; 95% CI, 1.440, 3.536; < 0.001).
The risk factors contributing to hyperkalemia were patients with older age, DM, CKD, hemodialysis treatment, and usage of RAASi. Although the usage of RAASi is proven to be a cardiovascular advantage in the elderly, DM, and CKD patients, careful monitoring of SK is strongly advised to optimize patient care.
高钾血症在门诊和急诊科是一种危及生命的状况。高钾血症与更多的主要不良心血管疾病事件、住院和死亡相关。本研究的目的是研究和评估泰国人群中发生高钾血症的患病率及危险因素。
在医学门诊对2021年一整年中3299例独特的成年患者(≥18岁)进行了一项横断面观察性研究,这些患者至少有1次有效的血清钾(SK)检测。高钾血症被定义为SK≥5.8 mmol/L且无溶血或技术误差。收集临床数据和实验室检查结果以分析危险因素。
2971例患者(131例高钾血症患者和2840例对照)符合条件。高钾血症的年患病率为4.41%。高钾血症组患者的平均年龄为66.5岁,对照组为55.9岁。年龄增加与高钾血症风险呈正相关(=0.220,<0.001),而估算肾小球滤过率(eGFR)与SK水平呈负相关(= -0.398,<0.001)。高钾血症的危险因素包括年龄≥65岁的患者(比值比,2.106;95%可信区间,1.399,3.171;<0.001)、患有糖尿病(DM,比值比,1.541;95%可信区间,1.030,2.306;=0.036)、慢性肾脏病(CKD)3期及以上(比值比,14.885;95%可信区间,8.112,27.313;<0.001)、血液透析治疗(比值比,10.170;95%可信区间,5.858,17.657;<0.001)以及使用肾素 - 血管紧张素 - 醛固酮系统抑制剂(RAASi,比值比,2.256;95%可信区间,1.440,3.536;<0.001)。
导致高钾血症的危险因素是老年患者、糖尿病、慢性肾脏病、血液透析治疗以及使用RAASi。尽管在老年患者、糖尿病患者和慢性肾脏病患者中使用RAASi已被证明具有心血管方面的益处,但强烈建议仔细监测血清钾以优化患者护理。